Cargando…

Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice

BACKGROUND: Interleukin-16 (IL-16) is an important inflammatory regulator and has been shown to have a powerful effect on the regulation of the inflammatory response. Cardiac inflammation has been reported to be closely related to doxorubicin- (DOX-) induced cardiac injury. In this study, the role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianwei, Yang, Zicong, Liang, Zhishan, Wang, Mengjie, Hu, Changxing, Chang, Chao, Shi, Lei, Ji, Qingwei, Liu, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075660/ https://www.ncbi.nlm.nih.gov/pubmed/33958974 http://dx.doi.org/10.1155/2021/6611085

Ejemplares similares

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)

Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice
por: Hu, Yewen, et al.
Publicado: (2022)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin‐induced cardiotoxicity
por: Hu, Can, et al.
Publicado: (2020)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice
por: Li, Gang, et al.
Publicado: (2020)

Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice
por: Yin, Na, et al.
Publicado: (2022)

Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis
por: Gao, Yunan, et al.
Publicado: (2016)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Corrigendum to “Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis”
por: Gao, Yunan, et al.
Publicado: (2017)

Coxsackievirus A16-like particles elicit neutralizing antibody responses in mice
por: Liu, Qingwei, et al.
Publicado: (2011)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis
por: Sun, Xutao, et al.
Publicado: (2021)

Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
por: Vandenwijngaert, Sara, et al.
Publicado: (2015)

Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice
por: Tsai, Tzu-Hsien, et al.
Publicado: (2019)

Higenamine Attenuates Doxorubicin-Induced Cardiac Remodeling and Myocyte Apoptosis by Suppressing AMPK Activation
por: Jin, Cuiliu, et al.
Publicado: (2022)

Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice
por: Ye, Jing, et al.
Publicado: (2018)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
por: Tony, Hasahya, et al.
Publicado: (2015)

Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation
por: Yang, Hsin-Lun, et al.
Publicado: (2020)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
por: Montalvo, Ryan N., et al.
Publicado: (2020)

The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells
por: Lee, Eun Ji, et al.
Publicado: (2023)

Comment on “MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction”
por: Oliveira-Carvalho, Vagner, et al.
Publicado: (2016)

Xinfuli improves cardiac function, histopathological changes and attenuate cardiomyocyte apoptosis in rats with doxorubicin-induced cardiotoxicity
por: Lu, Pei-Pei, et al.
Publicado: (2016)

Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice
por: Gertz, Zachary M., et al.
Publicado: (2019)

Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
por: Huang, Wen-Pin, et al.
Publicado: (2021)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023)

Novel polymorphism of interleukin-18 associated with greater inflammation after cardiac surgery
por: Shaw, David M, et al.
Publicado: (2009)

Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin
por: Lee, Beom Seob, et al.
Publicado: (2015)

Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2013)

Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response
por: Hadi, Najah, et al.
Publicado: (2012)

Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells
por: Kan, Lijuan, et al.
Publicado: (2015)

Acetaminophen Attenuates Doxorubicin-Induced Cardiac Fibrosis Via Osteopontin and GATA4 Regulation: Reduction of Oxidant Levels
por: Schunke, Kathryn J, et al.
Publicado: (2013)

Brain‐derived neurotrophic factor attenuates doxorubicin‐induced cardiac dysfunction through activating Akt signalling in rats
por: Hang, Pengzhou, et al.
Publicado: (2016)

Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis
por: Wang, Wen-Ke, et al.
Publicado: (2017)

Cardiac molecular pathways influenced by doxorubicin treatment in mice
por: Bulten, Ben F., et al.
Publicado: (2019)

Systemic and cardiac susceptibility of immune compromised mice to doxorubicin
por: Favreau-Lessard, Amanda J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnniitr3h1hctpr0v7c6dpojfs